Cassava Sciences Inc
Change company Symbol lookup
Select an option...
SAVA Cassava Sciences Inc
HYHG.EU ProShares High Yield-Interest Rate Hedged
DIDIY DiDi Global Inc
AWK American Water Works Company Inc
ASO Academy Sports and Outdoors Inc
GAB Gabelli Equity Trust
STRC Sarcos Technology and Robotics Corp
RLMD Relmada Therapeutics Inc
LMND Lemonade Inc
NAACW North Atlantic Acquisition Equity Warrant Exp 20 Oct 2025 *W EXP 10/20/2025
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is primarily focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimer's disease. The Company develops pharmaceutical product candidates that offer improvements to patients and healthcare professionals. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. The Company is conducting a Phase III program with Simufilam in patients with mild-to-moderate Alzheimer’s disease dementia. Its investigational product candidate, SavaDx, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. SavaDx is designed as an antibody-based detection system for altered filamin A (FLNA).

Premarket

Last Trade
Delayed
$50.60
4.42 (9.57%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$46.18
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
48,050

10-day average volume:
6,502,136
48,050
  • Prev Close
    46.18
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    6.5M
  • Last (time)
    4:00p ET 09/27/22
  • Last (size)
    8
  • 52-Wk Range
    13.84 - 100.00
    LowHigh
  • (11/04/21 - 07/27/22)
    233.67%
  • 118.6%
  • Market Cap
    1.9B
  • Shares Outstanding
    40.1M
  • -1.52
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 23.46
  • (% of float 09/15/22)
    33.68

Latest News

September 26, 2022
10:55 am ET
PR Newswire
September 23, 2022
9:31 am ET
PR Newswire
September 22, 2022
11:26 am ET
PR Newswire
September 21, 2022
10:45 am ET
PR Newswire
September 08, 2022
9:15 am ET
Globe Newswire
August 26, 2022
8:35 am ET
PR Newswire
August 21, 2022
9:00 pm ET
Globe Newswire
August 18, 2022
10:45 am ET
PR Newswire
9:15 am ET
Globe Newswire
August 17, 2022
8:32 am ET
PR Newswire
August 16, 2022
8:30 am ET
Globe Newswire
August 15, 2022
9:00 pm ET
Globe Newswire
August 12, 2022
10:50 pm ET
BusinessWire
August 10, 2022
9:00 pm ET
Globe Newswire
August 03, 2022
9:15 am ET
Globe Newswire
August 02, 2022
8:02 am ET
Accesswire
July 31, 2022
9:01 pm ET
Globe Newswire
July 29, 2022
10:50 pm ET
PR Newswire
July 28, 2022
4:23 pm ET
Globe Newswire
July 27, 2022
2:58 pm ET
MarketWatch
10:40 am ET
PR Newswire
July 25, 2022
11:02 pm ET
Globe Newswire
July 21, 2022
5:39 pm ET
Globe Newswire
July 20, 2022
9:00 pm ET
Globe Newswire
July 15, 2022
10:50 pm ET
BusinessWire
July 10, 2022
9:00 pm ET
Globe Newswire
July 07, 2022
9:41 pm ET
Newsfile
July 04, 2022
9:00 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.